3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
16
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
14
Triple Negative Breast Neoplasms
12
Lung Neoplasms
12
Neoplasm Metastasis
11
Squamous Cell Carcinoma of Head and Neck
8
Ovarian Neoplasms
8
Endometrial Neoplasms
7
Fallopian Tube Neoplasms
6
Esophageal Neoplasms
5
Oropharyngeal Neoplasms
4
Neoplasms
4
Melanoma
4
Colorectal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Inflammatory Breast Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Brenner Tumor
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Adenocarcinoma
2
Interventions
ruxolitinib
9
fludarabine phosphate
8
fludarabine
8
Whole-Body Irradiation
8
Specimen Handling
7
Cytarabine
7
Cyclophosphamide
7
Mycophenolic Acid
6
Tacrolimus
5
Injections
5
Busulfan
5
Biopsy
5
Azacitidine
5
Stem Cell Transplantation
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
CPX-351
4
venetoclax
3
luspatercept
3
decitabine and cedazuridine drug combination
3
Liposomes
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Blood Specimen Collection
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
selinexor
2
nilotinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Taxes
×
90 days
×
Clear all
No trials found.